Results 91 to 100 of about 8,048 (187)

Future Prospects of Imatinib in Advanced Pulmonary Hypertension Management

IUBMB Life, Volume 78, Issue 3, March 2026.
ABSTRACT Pulmonary arterial hypertension (PAH) is a severe, progressive disease characterized by elevated pulmonary arterial pressure and increased vascular resistance. This hemodynamic strain forces the right ventricle to pump against a high‐pressure system, ultimately leading to right‐sided heart failure and death.
Federica Davì, Stella Mangione, Antonella Iaconis, Tiziana Genovese, Nicla Tranchida, Salvatore Cuzzocrea   +5 more
wiley   +1 more source

Pulmonary tumor thrombotic microangiopathy and pulmonary veno-occlusive disease in a woman with cervical cancer treated with cediranib and durvalumab

BMC Pulmonary Medicine, 2018
Background Pulmonary tumor thrombotic microangiopathy (PTTM) is a rare cause of pulmonary hypertension that is associated with malignancies and is marked by the presence of non-occlusive tumor emboli and fibrocellular intimal proliferation of small ...
Dante A. Suffredini, Jung-Min Lee, Cody J. Peer, Drew Pratt, David E. Kleiner, Jason M. Elinoff, Michael A. Solomon   +6 more
doaj   +1 more source

Raske pulmonaalhüpertensiooniga kulgenud pulmonaalse kapillaarse hemangiomatoosi haigusjuht [PDF]

, 2009
Pulmonaalne hüpertensioon (PH) on kardiopulmonaalsüsteemi haigusseisund, mida iseloomustab vererõhu kõrgenemine kopsuarteris ja kopsuringe vaskulaarse resistentsuse tõus, mis viivad südame parema vatsakese puudulikkuse tekkeni. Üks haruldane PH põhjus on
Jalas, Tiiu, Laan, Mari, Plado, Silvi
core   +2 more sources

Vascular Reconstruction in Extremity Soft Tissue Sarcomas: A Systematic Review and Single‐Arm Meta‐Analysis

Journal of Surgical Oncology, Volume 133, Issue 4, Page 486-510, March 15, 2026.
ABSTRACT Introduction The management of extremity soft tissue sarcomas (STS) involving major vessels presents unique challenges, historically leading to amputation. Advances in vascular reconstruction have enabled limb‐sparing surgery (LSS), but outcomes and perioperative risks remain uncertain.
Lucas Monteiro Delgado, Bernardo Fontel Pompeu, Vinícius dos Santos Macedo, Gabriel Henrique Acedo Martins, Eric Pasqualotto, Matheus Reginato Araujo, Julia Hoici Brunini, Victor Andrade Nunes, Cláudia Theis, Samuel Aguiar Junior   +9 more
wiley   +1 more source

Pulmonary veno-occlusive disease

Revue des maladies respiratoires, 2018
Pulmonary veno-occlusive disease (PVOD) is a rare form of pulmonary hypertension (PH) characterized by preferential remodelling of pulmonary venules and angioproliferation. PVOD term includes idiopathic, heritable (biallelic mutations of EIF2AK4 gene), drugs and toxins induced (alkylating agents, organic solvents) and connectivite-associated forms ...
A, Boucly, B, Girerd, D, Bourlier, S, Nemlaghi, J, Caliez, L, Savale, X, Jaïs, P, Dorfmüller, G, Simonneau, O, Sitbon, M, Humbert, D, Montani   +11 more
openaire   +3 more sources

Pulmonary veno-occlusive disease misdiagnosed as idiopathic pulmonary arterial hypertension

European Respiratory Review, 2009
A 27-yr-old female with a 6-month diagnosis of idiopathic pulmonary arterial hypertension (PAH) confirmed elsewhere was referred to our centre with worsening dyspnoea.
M. Palazzini, A. Manes
doaj  

Complete Resection of a Giant Mediastinal Liposarcoma Extending Into Both Pleural Cavities via Median Sternotomy: A Case Report

Clinical Case Reports, Volume 14, Issue 2, February 2026.
ABSTRACT Surgical resection is the primary treatment for giant mediastinal liposarcoma. However, aggressive R0 resection involving major nerves can lead to fatal functional loss. Clinicians must balance oncological radicality with functional preservation, as early diagnosis remains the most critical factor for avoiding highly morbid, extensive ...
Shin‐nosuke Watanabe, Daisuke Kimura, Takahiro Sasaki, Shuta Kimura, Chisaki Ichinohe, Shiori Ono, Hirose Imai, Masahito Minakawa   +7 more
wiley   +1 more source

Current pathophysiological concepts and management of pulmonary hypertension [PDF]

, 2012
Pulmonary hypertension (PH), increasingly recognized as a major health burden, remains underdiagnosed due mainly to the unspecific symptoms. Pulmonary arterial hypertension (PAH) has been extensively investigated.
Fontoura, D, Henriques-Coelho, T, Leite-Moreira, AF, Lourenço, AP   +3 more
core   +1 more source

Stem Cell Therapy for Inflammatory Diseases: Progress, Challenges, and Future Directions

MedComm, Volume 7, Issue 2, February 2026.
Stem cells offer multifaceted therapeutic approaches for inflammatory diseases, each exhibiting distinct therapeutic properties. Hematopoietic stem cells, primarily through hematopoietic stem cell transplantation (HSCT), can effectively remodel the immune environment, showing particular promise in treating genetically linked cases.
Chen Wu, Zhi‐Ping Jin, Shu‐Qiang Weng, Ji‐Min Zhu, Ling Dong   +4 more
wiley   +1 more source

Rapid disease progress in a PVOD patient carrying a novel EIF2AK4 mutation: a case report

BMC Pulmonary Medicine, 2020
Background Pulmonary veno-occlusive disease (PVOD) and pulmonary arterial hypertension (PAH) share an overlapping disease phenotype. Hence it is necessary to distinguish them.
Xiaofang Zeng, Fan Chen, Anandharajan Rathinasabapathy, Tangzhiming Li, Agila Adnan Ali Mohammed Mohammed, Zaixin Yu   +5 more
doaj   +1 more source